Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -185.94% is 68% below its 5-year average of -110.62%, near the low end of its 5-year range (-195.66%–-60.96%).
11.75% below its 12-month average of -166.39%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -64.19%.
RETURN ON ASSETS (ROA)
-185.94%
RETURN ON ASSETS (ROA) AVG TTM
-166.39%
RETURN ON ASSETS (ROA) AVG 3Y
-133.67%
RETURN ON ASSETS (ROA) AVG 5Y
-110.62%
RETURN ON ASSETS (ROA) AVG 10Y
-86.22%
RETURN ON ASSETS (ROA) AVG 15Y
-68.10%
RETURN ON ASSETS (ROA) AVG 20Y
-81.58%
CURRENT VS TTM AVG
-11.75%
CURRENT VS 3Y AVG
-39.11%
CURRENT VS 5Y AVG
-68.09%
CURRENT VS 10Y AVG
-115.66%
CURRENT VS 15Y AVG
-173.03%
CURRENT VS 20Y AVG
-127.94%
SECTOR MEDIAN · HEALTHCARE
-31.48%
median of 786 covered companies
CURRENT VS SECTOR MEDIAN
-490.75%
vs the sector median at left
Cerenome, Inc.
Market Cap
$10.88M
Return on Assets (ROA)
-185.94%
TTM Avg
-166.39%
3Y Avg
-133.67%
5Y Avg
-110.62%
Market Cap
$10.96M
Return on Assets (ROA)
-404.58%
TTM Avg
-269.82%
3Y Avg
-269.82%
5Y Avg
-269.82%
Market Cap
$11.24M
Return on Assets (ROA)
-198.70%
TTM Avg
-189.50%
3Y Avg
-187.22%
5Y Avg
-200.18%
Market Cap
$11.12M
Return on Assets (ROA)
-46.21%
TTM Avg
-17.41%
3Y Avg
-49.70%
5Y Avg
-52.01%
Market Cap
$11.12M
Return on Assets (ROA)
-154.89%
TTM Avg
-40.68%
3Y Avg
-87.98%
5Y Avg
-439.28%
Market Cap
$10.65M
Return on Assets (ROA)
-132.59%
TTM Avg
-75.28%
3Y Avg
-65.73%
5Y Avg
-52.31%
Market Cap
$11.27M
Return on Assets (ROA)
-98.26%
TTM Avg
-77.06%
3Y Avg
-65.68%
5Y Avg
-62.77%
Market Cap
$10.63M
Return on Assets (ROA)
-88.09%
TTM Avg
-90.94%
3Y Avg
-60.82%
5Y Avg
-50.49%
Market Cap
$10.51M
Return on Assets (ROA)
N/A
TTM Avg
-37.02%
3Y Avg
-41.41%
5Y Avg
-41.74%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cerenome, Inc. (CNSY) | $10.88M | -185.94% | -166.39% | -133.67% | -110.62% |
| Caring Brands, Inc. (CABR)vs › | $10.96M | -404.58% | -269.82% | -269.82% | -269.82% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.24M | -198.70% | -189.50% | -187.22% | -200.18% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.12M | -46.21% | -17.41% | -49.70% | -52.01% |
| BioVie Inc. (BIVI)vs › | $11.12M | -154.89% | -40.68% | -87.98% | -439.28% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.65M | -132.59% | -75.28% | -65.73% | -52.31% |
| Pluri Inc. (PLUR)vs › | $11.27M | -98.26% | -77.06% | -65.68% | -62.77% |
| Lifeward Ltd. (LFWD)vs › | $10.63M | -88.09% | -90.94% | -60.82% | -50.49% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.51M | N/A | -37.02% | -41.41% | -41.74% |
| Biofrontera Inc. (BFRI)vs › | $11.39M | -26.45% | -58.62% | -47.64% | -51.16% |
ROA
-185.9%
ROE
-477.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -137.13% |
| 2024-12-31 | -195.66% |
| 2023-12-31 | -116.93% |
| 2022-12-31 | -84.95% |
| 2021-12-31 | -60.96% |
| 2020-12-31 | -68.08% |
| 2019-12-31 | -46.87% |
| 2018-12-31 | -52.66% |
| 2017-12-31 | -71.76% |
| 2016-12-31 | -63.70% |
| 2015-12-31 | -49.72% |
| 2014-12-31 | -96.51% |
| 2013-12-31 | -62.24% |
| 2012-12-31 | -74.63% |
| 2011-12-31 | -62.97% |
| 2010-12-31 | -41.44% |
| 2009-12-31 | -93.81% |
| 2008-12-31 | -117.29% |
| 2007-12-31 | -133.31% |
| 2006-12-31 | -102.33% |
| 2005-12-31 | -94.22% |
| 2004-12-31 | -8.21% |
| 2003-12-31 | -33.05% |
| 2002-12-31 | -33.07% |
| 2001-12-31 | -25.98% |
| 2000-12-31 | -16.54% |
| 1999-12-31 | -81.99% |
| 1998-12-31 | -204.90% |
